Accuray (ARAY) Free Cash Flow Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Accuray | 47,295.88 | -38.49 Mn | 25.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.26% |
| Dec 31, 2025 | -25.31% |
| Sep 30, 2025 | 40.00% |
| Mar 31, 2025 | 22.68% |
| Dec 31, 2024 | -56.12% |
| Sep 30, 2024 | 21.47% |
| Mar 31, 2024 | -25.06% |
| Dec 31, 2023 | 19.34% |
| Sep 30, 2023 | 14.29% |
| Mar 31, 2023 | 5.86% |
| Dec 31, 2022 | -59.63% |
| Sep 30, 2022 | 70.53% |
| Mar 31, 2022 | 39.22% |
| Dec 31, 2021 | 48.48% |
| Sep 30, 2021 | -4.52% |
| Mar 31, 2021 | 36.98% |
| Dec 31, 2020 | 27.98% |
| Sep 30, 2020 | -18.34% |
| Jun 30, 2020 | 43.74% |
| Mar 31, 2020 | -55.17% |
| Dec 31, 2019 | 126.46% |
| Sep 30, 2019 | -8.26% |
| Jun 30, 2019 | 0.07% |
| Mar 31, 2019 | -22.32% |
| Dec 31, 2018 | -21.89% |
| Sep 30, 2018 | -6.08% |
| Jun 30, 2018 | 35.52% |
| Mar 31, 2018 | 15.66% |
| Dec 31, 2017 | 44.19% |
| Sep 30, 2017 | 5.46% |
| Jun 30, 2017 | 35.35% |
| Mar 31, 2017 | -55.69% |
| Dec 31, 2016 | -22.54% |
| Sep 30, 2016 | 30.66% |
| Jun 30, 2016 | -3.90% |
| Mar 31, 2016 | -1.59% |
| Dec 31, 2015 | -8.62% |
| Sep 30, 2015 | 23.94% |